Inside the Clinic: Myelofibrosis

Experts from the John Theurer Cancer Center reflect on the real-world management of patients with myelofibrosis at their institution.

EP. 11: Factors Informing Selection and Use of JAK Inhibitors in Myelofibrosis

August 22nd 2023

Panelists consider the patient and disease factors that might indicate use of a specific JAK inhibitor when managing patients with myelofibrosis.

EP. 12: Evolving Treatment Landscape of Myelofibrosis

August 29th 2023

Closing out their discussion on myelofibrosis management, experts from the John Theurer Cancer Center consider novel therapies under investigation and the future treatment paradigm.